Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosisArticle Published on 2022-12-312023-07-08 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), [키워드] adverse events BBIBP-CorV multiple sclerosis SARS-CoV-2, COVID-19 vaccines vaccine safety. [DOI] 10.1080/21645515.2022.2041945 PMC 바로가기
Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumabArticle Published on 2022-12-232023-07-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), [키워드] B cell response COVID-19 multiple sclerosis Ocrelizumab SARS-CoV-2 T cell response vaccination. [DOI] 10.3389/fimmu.2022.1037214 PMC 바로가기
Humoral efficacy of the third SARS-CoV-2 vaccine dose in Multiple Sclerosis subjects undergoing different disease-modifying therapiesArticle Published on 2022-12-012023-07-11 Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), [키워드] BNT162b2 booster vaccine Coronavirus disease 2019 (COVID-19) Disease modifying therapies Humoral response multiple sclerosis Severe acute respiratory syndrome coronavirus (SARS-CoV)-2. [DOI] 10.1016/j.msard.2022.104371 PMC 바로가기
Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinationsResearch article Published on 2022-12-012022-10-05 Journal: Multiple sclerosis and related disorders [Category] 진단, [키워드] Central nervous system CNS collected COVID-19 COVID-19 vaccination Demyelinating disease demyelination disease disease disease manifestation disease onset disorder Inflammatory investigated MOG MOG antibody-associated disease multiple sclerosis Neuromyelitis optica spectrum disorder observation Onset proportion Registered Result susceptible individuals vaccination [DOI] 10.1016/j.msard.2022.104141 [Article Type] Research article
Signs and symptoms of COVID-19 in patients with multiple sclerosisArticle Published on 2022-12-012022-11-16 Journal: European journal of neurology [Category] COVID19(2023년), SARS, 변종, [키워드] affected Ageusia alcohol Analysis Anosmia anti-CD20 therapy association chest pain clinical collected Comorbidity coronavirus disease COVID-19 COVID-19 symptom COVID-19 symptoms Delta Demyelinating diseases difference disease-modifying treatment Factor flu-like symptom Frequency greater identify Infection investigated joint less Linear regression model multiple sclerosis Neurological disorders neurological disorders. number of symptom Occurrence Odds ratio Older outcome Pain Patient Rash recognize risk factor Shortness of breath SIGN similarity smoke smoker Symptom symptoms of COVID-19 Tachycardia therapeutic approach therapy variant [DOI] 10.1111/ene.15554 PMC 바로가기
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimodArticle Published on 2022-12-012022-11-15 Journal: Journal of Neurology [Category] COVID19(2023년), SARS, 진단, [키워드] binding antibody unit BNT162b2 mRNA BNT162b2 mRNA vaccine booster dose collected Control COVID-19 COVID-19 vaccine dose expressed fingolimod HCs humoral Humoral response IgG IgG antibody IgG level Laboratory mRNA mRNA vaccine Multiple multiple sclerosis Ocrelizumab Ocrelizumab. of BNT162b2 Patient positive predict quantified reported SARS-CoV-2 sclerosis serum sample severe adverse event socio-demographic threshold Tolerability treated Trimeric spike protein Vaccine vaccine dose variable [DOI] 10.1007/s00415-022-11296-4 PMC 바로가기
Quantitative and qualitative features of acute phase-adverse events following SARS-CoV-2 vaccination in a large sample of people with multiple sclerosisArticle Published on 2022-12-012023-07-10 Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), [키워드] adverse events COVID Disease modifying treatments multiple sclerosis SARS-CoV-2 Vaccines. [DOI] 10.1016/j.msard.2022.104120 PMC 바로가기
Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov2 Spike in patients with immune system diseasesArticle Published on 2022-12-012023-07-10 Journal: Journal of autoimmunity [Category] COVID19(2023년), [키워드] antibody COVID-19 Glucocorticoids IGRA immune system diseases multiple sclerosis sarcoidosis spike systemic lupus erythematosus vasculitis. [DOI] 10.1016/j.jaut.2022.102912 PMC 바로가기
Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosisObservational Study Published on 2022-12-012023-07-10 Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), [키워드] Demyelination multiple sclerosis Neuromyelitis optica spectrum disorders Remission SARS-CoV-2 Vaccination. [DOI] 10.1016/j.msard.2022.104167 PMC 바로가기 [Article Type] Observational Study
Vaccinations in patients with multiple sclerosis: a real-world, single-center experienceArticle Published on 2022-11-302023-07-10 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), [키워드] immunization multiple sclerosis therapy switch Timing Vaccines. [DOI] 10.1080/21645515.2022.2099171 PMC 바로가기